Hologic (HOLX +1.6%) ticks higher after JPMorgan ups the shares to Overweight. The firm says the...


Hologic (HOLX +1.6%) ticks higher after JPMorgan ups the shares to Overweight. The firm says the upgrade was made to reflect compelling risk/reward and synergies from the Gen-Probe (GPRO) deal. Its price target is also raised to $22 from $20.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs